Alida Biosciences is developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays.

Alida Biosciences

Introducing the EpiPlex™ RNA Reagent Kit: Multiplexed Epigenomics has arrived!

We are excited to announce the early access launch of the EpiPlex RNA Assay, designed to empower researchers with unprecedented insights into Epitranscriptomics. Say goodbye to the limitations of existing methods and embrace a new era of accuracy, sensitivity, and ease in epitranscriptomic analysis.

Key Features of the EpiPlex RNA Reagent Kit:
✅ Multiplexed Detection: Our proximity barcoding-based assay enables simultaneous detection of multiple RNA modifications in mRNA and long ncRNA.
✅ High Sensitivity: With a sensitivity that allows for analysis of clinical samples using just 20 ng of mRNA input, our assay ensures reliable results even with limited starting material.
✅ Enhanced Quantitative Analysis: Using next-gen sequencing as a readout, the assay reports on RNA modification identity, location, and relative quantification at each locus.
✅ Streamlined Workflow: The multiplexed assay design reduces variability across experiments and the user-friendly customer pipeline to analyze the new data types makes the epitranscriptome as accessible as traditional RNA-Seq.
✅ Early Access Availability: Be among the first to experience the power of multiplexed epigenomics! The EpiPlex RNA Assay is now available as an early access reagent kit, putting cutting-edge technology at your fingertips.

Unlock the Potential of Epitranscriptomics with Alida Bio.

Contact us at orders@alidabio.com today to learn more about the EpiPlex RNA Reagent Kit and begin your journey toward groundbreaking discoveries in epitranscriptomics!
#Epitranscriptomics #RNAmodifications #EpiPlex #RNASeq #AlidaBio #Epigenomics

 


CrUX Dataset

CrUX Top 50m

Co-Founder

Byron Purse

CEO & Co-Founder

Gudrun Stengel

Vice President of Research and Development

Andrew Price

Director, Protein Engineering

Zachary Miles

Biotechnology R&D - Product Development Leader - Operations & Customer Success

John Chevillet

Principal Scientist

Hua Yu

Scientist II

Jerome Santos

Senior Scientist- Protein Engineering

Jungki Min

John Drewry

Landon Merrill

CEO & Founder

Health Care Companies With More Than 10 Employees (Top 10K)

Health Care Female Founded Companies with Early Stage Venture Funding

Western US Companies With Fewer Than 1000 Employees (Top 10K)

Health Care Early Stage Companies With Fewer Than 100 Employees

Alida Biosciences is a biotech company creating RNA analysis tools to improve human health. The company was founded in 2020 and is headquartered in San Diego, CA.

Genoa Ventures

Series A - Alida Biosciences

National Human Genome Research Institute

Grant - Alida Biosciences

Seed Round - Alida Biosciences

Pre Seed Round - Alida Biosciences

San Diego

California

United States

North America

Alida Biosciences Raises $7.5M in Series A Funding

Alida Biosciences Announces Series A Funding and Early Access Launch of Innovative Products for Epitranscriptomic Research

Alida Biosciences Raises $7.5 Million Series A

AlidaBio lands $7.5m to advance epigenetic analysis technology

Philippines

Asia

Turkey

Europe

India

Bangladesh

MiRXES is a biotechnology company specializing in developing innovative RNA analysis tools for medical treatments and diagnostic assays.

MiRXES

Humacyte is a biotechnology company focused on developing medical treatments and diagnostic assays, particularly in the field of RNA analysis tools.

Humacyte

eTheRNA is a biotechnology company specializing in RNA analysis tools and the development of innovative medical treatments and diagnostic assays.

eTheRNA

ProMab Biotechnologies is a company that focuses on developing and commercializing products and services in the biotechnology and healthcare sectors, including RNA analysis tools.

ProMab Biotechnologies

Evommune is a biotechnology company that specializes in developing innovative solutions in the field of biotechnology, particularly in RNA analysis tools and medical treatments.

Evommune

Alidabio is a company that specializes in providing innovative solutions in the field of biotechnology. The company focuses on developing and commercializing products and services that cater to the needs of the healthcare and life sciences sectors.

Alidabio

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jun 21, 2024 10:03 PM	8b6c3f82
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 22, 2024 1:03 AM	278c7348
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:51 PM	21505fe8
crunchbase profile	general	Oct 29, 2024 8:25 AM	8f6feede
li profile	general	Jun 21, 2024 10:03 PM	d0ec83c1
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	dab59ed6
peers	general
news basic	general	Jun 21, 2024 10:03 PM	e3bcd31e
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ALIDABIO

Alidabio